| |
| |
|
| Insider
Information: |
Mcglynn Margaret G |
| Relationship: |
Director |
| City: |
Whitehouse Station |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
75,114 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$842,100 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
75,114 |
|
|
| Total
Value |
$842,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2022-05-01 |
178 |
2012-11-07 |
0 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
|
2024-06-06 |
71,136 |
2015-11-10 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,801 |
8,113 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,801) |
4,124 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-08-13 |
4 |
AS |
$185.00 |
$1,850,000 |
D/D |
(10,000) |
4,124 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-08-13 |
4 |
OE |
$81.54 |
$815,400 |
D/D |
10,000 |
14,124 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-10-22 |
4 |
AS |
$190.00 |
$3,800,000 |
D/D |
(20,000) |
4,124 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-10-22 |
4 |
OE |
$72.14 |
$1,442,800 |
D/D |
20,000 |
24,124 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
239 |
3,885 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
4,584 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2021-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
921 |
1,798 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2021-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(699) |
1,099 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-01-28 |
4 |
AS |
$240.53 |
$1,208,960 |
D/D |
(5,000) |
1,099 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-01-28 |
4 |
OE |
$127.54 |
$637,700 |
D/D |
5,000 |
6,099 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-03-31 |
4 |
AS |
$261.28 |
$1,311,346 |
D/D |
(5,000) |
1,099 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-03-31 |
4 |
OE |
$127.54 |
$637,700 |
D/D |
5,000 |
6,099 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-08 |
4 |
AS |
$280.19 |
$1,401,080 |
D/D |
(5,000) |
1,099 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-08 |
4 |
OE |
$127.54 |
$637,700 |
D/D |
5,000 |
6,099 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-05-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(921) |
178 |
0 |
- |
|
67 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
